Kets Carolien M, Hoogerbrugge Nicoline, Bodmer Danielle, Willems Riki, Brunner Han G, van Krieken Joannes H J M, Ligtenberg Marjolijn J L
Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Mod Pathol. 2006 Dec;19(12):1624-30. doi: 10.1038/modpathol.3800701. Epub 2006 Sep 15.
A high degree of microsatellite instability (MSI) in colorectal cancer (CRC) is a hallmark of hereditary non-polyposis colorectal cancer (HNPCC), caused by germline defects in the mismatch repair (MMR) genes. A low degree of instability (less than 30% of the microsatellites) is seen in a subset of tumors. To clarify the significance of this low degree of MSI phenotype, we studied the differences between patients with colorectal tumors with high-level, low-level and no MSI. Colorectal tumors with no (n = 68) and low-level (n = 18) MSI of patients clinically suspected of HNPCC were compared to colorectal tumors with high-level MSI (n = 12) of patients that carry a pathogenic germline mutation in a MMR gene. Compared to tumors with no MSI, tumors with low-level MSI were classified more frequently as stage T3 or T4 (100% vs 68% respectively), and showed less immune response (P = 0.02). No significant differences in familial CRC risk were found by comparing pedigrees of these two groups of tumors. Compared to the group of tumors with high-level MSI, the group of tumors with low-level MSI had a less suspicious family history, a higher percentage of lymph node metastasis (56 vs 17%), and less immune response. Thus, with respect to genetic risks, familial CRC can be divided into two groups: Tumors with high-level MSI and tumors with low-level or no MSI. However, tumors with low-level MSI show unfavorable pathological characteristics compared to tumors with no and tumors with high-level MSI. These differences suggest a distinct underlying biology of CRC with low-level MSI.
结直肠癌(CRC)中高度微卫星不稳定(MSI)是遗传性非息肉病性结直肠癌(HNPCC)的标志,由错配修复(MMR)基因的种系缺陷引起。在一部分肿瘤中可见低度不稳定(微卫星的比例低于30%)。为了阐明这种低度MSI表型的意义,我们研究了高、低和无MSI的结直肠肿瘤患者之间的差异。将临床怀疑为HNPCC患者的无MSI(n = 68)和低度MSI(n = 18)的结直肠肿瘤与携带MMR基因致病性种系突变患者的高度MSI结直肠肿瘤(n = 12)进行比较。与无MSI的肿瘤相比,低度MSI的肿瘤更常被分类为T3或T4期(分别为100%和68%),且免疫反应较弱(P = 0.02)。通过比较这两组肿瘤的家系,未发现家族性CRC风险有显著差异。与高度MSI的肿瘤组相比,低度MSI的肿瘤组家族史可疑性较低,淋巴结转移百分比更高(56%对17%),免疫反应较弱。因此,就遗传风险而言,家族性CRC可分为两组:高度MSI的肿瘤和低度或无MSI的肿瘤。然而,与无MSI和高度MSI的肿瘤相比,低度MSI的肿瘤显示出不利的病理特征。这些差异表明低度MSI的CRC具有独特的潜在生物学特性。